---
$id: https://graph.org.ai/products/commodity/51162614
$type: Product
source: UNSPSC
code: "51162614"
title: "Caramiphen"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Caramiphen

**UNSPSC Code**: 51162614
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C18H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 97J7NP0XJY, chemically known as cyclopentanecarboxylic acid, 1-phenyl-, 2-(diethylamino)ethyl ester but more generally known as caramiphen, which bears US NIH Compound Identifier 6472. Caramiphen most often comes in base, ethanedisulfonate, hydrochloride, and hydrogen edisilate. European Medicines Agency schedules Caramiphen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06085MIG. The term CARAMIPHEN is an International Non-Proprietary Name. CARAMIPHEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule caramiphen under HS 29221980 and SITC 51461. As of Q4 2014, CARAMIPHEN remains US FDA's Preferred Term for this commodity. Caramiphen bears US NLM identifiers UMLS ID C0054635 and NCI Concept Code C81594. SMILES: O(C(=O)C1(CCCC1)C1CCCCC1)CCN(CC)CC.

